Clinical development of medicinal products intended for the treatment of pain

  • Email
  • Help
Current version

Adopted guideline

 

Reference numberEMA/CHMP/970057/2011
Published22/01/2016
Effective from01/07/2017 
KeywordsPain, neuropathic, nociceptive, chronic, acute, analgesia
DescriptionThis guideline is intended to provide guidance on the clinical development of new medicinal products for the treatment of pain. It replaces and updates the separate guidelines on neuropathic and nociceptive pain (superseeded documents below).


Document history

First version

Current version

Adopted guideline

 

Draft guideline - Corr. 1


Draft guideline


Concept paper

In operation: 01/07/2017-present

 

Published: 21/12/2015


Published: 30/05/2013


Published: 29/09/2011

Document to be superseded

Adopted guideline


Overview of comments


Draft guideline

In operation: 31/06/2007–present


Published: 24/01/2007


Published: 26/01/2006

Document to be supersededAdopted guidelineIn operation: 01/05/2003–present


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more